Author

Wanling Zhu

Yale UniversityORCID 0000-0003-0084-4943Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1 Assay:metabolomics· 1

Frequent Co-Authors

Andrew WangiD· 2 shared Cuiling ZhangiD· 2 shared Rachel J. PerryiD· 2 shared Xinyi ZhangiD· 2 shared Zongyu LiiD· 2 shared Adebowale AdeniraniD· 1 shared Alexandra A. HalberstamiD· 1 shared Ali R. NasiriiD· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

Andrew WangORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PhysiologybioRxivPreprintJun 22, 2023

GDF15 is a Critical Renostat in the Defense Against Hypoglycemia

Zongyu Li, Xinyi Zhang, Wanling Zhu…·Rachel J. Perry

This study identifies GDF15 as a new hypoglycemia counterregulatory hormone, showing it increases hepatic gluconeogenesis through renal release and beta-adrenergic receptor-2 signaling.

2 citations

mouseexperimental assay

𝕏 PostBluesky

PhysiologybioRxivPreprintApr 12, 2023

FGF-21 Conducts a Liver-Brain-Kidney Axis to Promote Renal Cell Carcinoma

Zongyu Li, Xinyi Zhang, Wanling Zhu…·Rachel J. Perry

This study identifies FGF-21's role in promoting renal gluconeogenesis through a liver-brain-kidney axis, linking it to accelerated renal cell carcinoma progression and suggesting Adrb2 blockade as a potential therapy.

7 citations

mousehuman

𝕏 PostBluesky